Healthy Japanese adults
Conditions
Interventions
Duration: 4 weeks Test beverage: Kiseisui Dose and direction: Drink 30 mL before the dinner *If you forget to drink the test beverage drink it between after dinner to before going to bed
Sponsors
ORTHOMEDICO Inc.
Seishin-kai Medical Association Inc, Takara Medical Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Japanese people who are 40 or more to less than 70 years old with experiencing fatigue 2. Those who are considered as appropriate for the study by the physician 3. Within 2, Priority selection is made in the order of II: warning zone, III: observation zone, and IV: safety zone, in immunological grade at baseline, and V: sufficiently high and I: critical zone are excluded
Exclusion criteria
Exclusion criteria: 1. At least one previous medical history or under the treatment of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Those who use or take "Foods for Specified Health Uses" and "Foods with Functional Claims" in daily 4. Those who are smokers 5. Currently taking medicines and/or herbal medicines 6. Those who are allergic to medicines, milk, beans, orange, and/or other food products 7. Those who are pregnant, breast-feeding, and plan to become a pregnant 8. Those who had participated another clinical test for three months when you signed the informed consent form for this trial 9. Others considered as inappropriate for the study by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scoring of immunological vigor *Assess at 0 and 4 weeks after consuming | — |
Secondary
| Measure | Time frame |
|---|---|
| Immunity test T lymphocyte age, T cells, CD4+T cells / CD8+T cells ratio, naive T cells, naive T cells / memory T cells ratio, B cells, NK cells, CD4+T cells, CD8+T cells, CD8+CD28+T cells, memory T cells *Assess at 0 and 4 weeks after consuming | — |
Countries
Japan
Contacts
Public ContactNaoko SUZUKI
ORTHOMEDICO Inc. R&D Department
Outcome results
None listed